RightRep EN · PT Open the app
BLOG

Can You Train With Hip Pain? The Umbrella-Door Audit: The Door the Hip Wing Left Closed (What the Research Says)

By RightRep AI Assistant · · 21 min read

The hip wing of this library is already built: the hip replacement door, the bursitis door, the hip flexor strain door, the groin, hamstring and quad strain doors, and the shared osteoarthritis door. But every one of those doors assumes the reader holds a diagnosis. "Can I train with hip pain?" is asked by the reader who holds nothing but pain — a pinch in the groin at the bottom of a squat, an ache on the side of the hip that flares lying on it at night, a stiffness after the long run — no MRI sentence attached, no specialist's letter, just two opposite internet scripts screaming from either side: "stop loading it or you'll need a new hip" and "squat through it, hips are supposed to be tight." The studies below were read directly; every number in this guide comes from an abstract checked against its claim. The short version: the panic script is priced wrong (three-quarters of new hip-pain patients are not on a joint-replacement trajectory even four years later [5]), the scan script is priced wrong (a majority of pain-free hips carry the findings that scare you [3][4]), and the honest answer is a triage step followed by a load-management protocol — not a yes, and definitely not a no.

Here is the shape of the file before the receipts. The condition pool behind this door is the largest in musculoskeletal medicine: 595 million people — 7.6% of humanity — had osteoarthritis in 2020, and the hip is its fastest-growing large-joint projection at +78.6% to 2050 [1]. Yet the symptom pool is a fraction of the imaging pool: among adults over fifty, 19.6% have X-ray hip arthritis but only 4.2% have hip arthritis that hurts [2] — and in pain-free hips, labral tears sit in 54% and impingement-shaped sockets in the majority [3][4]. When the pain does arrive in primary care, 7% of new presenters are listed for a hip replacement within a year and 23% within four years — leaving three-quarters on no such trajectory at all [5]. When the pain is the classic lateral-hip ache of gluteal tendinopathy, the trial file is one-sided: education plus exercise beat both the corticosteroid injection and wait-and-see on global improvement at eight weeks (51/66 vs 38/65 vs 20/68, NNT 2.0 against doing nothing) — and was still ahead of the injection at fifty-two weeks [6]. When it is the joint itself, the file is more honest than the knee's: one randomized trial of physical therapy vs sham ultrasound for hip osteoarthritis found no significant difference [7] — while twelve weeks of heavy progressive resistance training improved hip-OA pain by ~9 points, matching the clinical-standard neuromuscular program exactly [8], and the guideline house keeps exercise in core management for hip and knee alike [9]. When it is impingement and the question is the surgeon, three randomized trials price the margin: arthroscopy beat structured physiotherapy by 6.8 iHOT-33 points at 12 months (just past the 6.1 MCID) [10] and 10.0 HOS-ADL points at 8 months [11] — with the physiotherapy arms still improving by double digits and the structural endpoint at 38 months showing no difference in joint-space width [12]. And the population this library serves is already living the answer: among 113 competitive Brazilian bodybuilders, 7% had hip pain in the preceding week and not one symptomatic athlete interrupted training [14]. The danger at this door is not the squat rack. It is the six months of waiting for a pain-free day that the evidence says not to wait for — spent reading an MRI report that half the pain-free world shares [3][4].

The scale of the door: the biggest joint file in medicine

Osteoarthritis is not a niche file, and the hip is its structural center of gravity. The Global Burden of Disease 2021 analysis put 595 million people (95% UI 535–656) — 7.6% (6.8–8.4) of the global population — living with osteoarthritis in 2020, a 132.2% rise in total cases since 1990, with the knee the most common site, osteoarthritis already the seventh-ranked cause of years lived with disability in adults over seventy, high BMI contributing 20.4% of the burden — and, the projection that sizes this door's future, hip osteoarthritis cases projected to grow 78.6% (57.7–105.3) by 2050, the steepest large-joint curve behind only the miscellany [1]. The community census that anchors the ratio comes from Framingham: 978 adults aged 50 and over, age-standardised radiographic hip osteoarthritis (KL ≥2) at 19.6% (95% CI 16.7–23.0%) — against symptomatic hip osteoarthritis at 4.2% (2.9–6.1%) [2]. Read those two numbers together and this door's central paradox appears: one in five hips over fifty shows the arthritis on film; one in twenty-five hurts with it [2]. The gap between those figures — four hips carrying the X-ray for every hip carrying the pain — is the space where most of this door's readers actually live, and it is why the first move below is triage, not imaging. Nothing in a scan, by itself, tells you whether your pain is the scan.

The scan is not the pain: what pain-free hips carry

The reader at this door rarely arrives empty-handed — they arrive with a report. Maybe a friend's MRI language, maybe their own: cam morphology, pincer morphology, labral tear. The imaging-literacy file prices exactly how much that language should frighten someone who trains. The systematic review of 26 studies and 2,114 asymptomatic volunteer hips (mean age 25.3) found cam deformity in 37% — 54.8% in athletes versus 23.1% of the general population — pincer deformity in 67% (61–76), and labral injury on MRI in 68.1%, with a mean alpha angle of 54.1°±5.1 sitting comfortably in the "impingement" range these reports quote [4]. The BJSM meta-analysis of 29 studies sharpens the contrast in the direction that matters: labral tears in 54% (41–66) of asymptomatic hips versus 62% (47–75) of painful ones — a 8-point gap between the tear and the hurt — while cartilage defects, the finding that genuinely matters, run 12% (7–21) pain-free versus 64% (25–91) symptomatic [3]. The translation for the pre-squat reader: the shapes are near-universal in athletic populations and mean almost nothing by themselves; the cartilage is where symptom risk actually concentrates [3][4]. An MRI sentence without an examination is a population statistic, not a prognosis — which is why this door hands off to clinicians for interpretation instead of issuing verdicts, and why the hip bursitis door and the osteoarthritis door each open from a diagnosis rather than a download.

The prognosis column: what actually happens to new hip pain

The fear at this door has a specific shape — this ache is the first page of a hip-replacement story — and the primary-care cohort that followed new presenters prospectively prices that fear honestly. Of new patients arriving in general practice with hip pain, 7% were listed for total hip replacement within 12 months, and 23% within four years [5]. Flip the denominator: three-quarters of new hip-pain patients were not on a joint-replacement trajectory even at four years [5]. The predictors that did the listing were clinical and legible — pain duration, pain severity including stick use, and restricted internal rotation — and a combined clinical-plus-radiographic score reached 76% sensitivity and 95% specificity for predicting replacement [5], which is exactly the assessment a clinician performs and this guide does not. What fills the four years for the majority is the conservative file, and the wait-and-see arm of the lateral-hip trial shows what not treating it buys: at eight weeks, only 20 of 68 wait-and-see patients rated themselves globally improved, and even at fifty-two weeks only 31 of 60 did — roughly half not improved after a year of waiting [6]. Untreated hip pain does not politely resolve on schedule; treated, it answers to programs [6][8]. The hip replacement door exists for the quarter who end up there — and even they come back to the barbell on the other side.

The lateral-hip file: the trial where exercise beat the injection

The single most common resident behind the undiagnosed lateral ache — pain on the side of the hip, worse lying on it, worse crossing legs, tender over the greater trochanter — is gluteal tendinopathy, and it owns one of the cleanest three-arm trials in this wing. The LEAP trial randomized 204 patients (167 women, mean age 54.8) to education plus exercise (EDX), to a corticosteroid injection (CSI), or to wait-and-see (WS) [6]. At eight weeks, global improvement — the patient's own verdict — ran 51/66 with exercise, 38/65 with the injection, 20/68 with nothing: exercise versus wait-and-see risk difference 49.1% (95% CI 34.6–63.5), NNT 2.0 (1.6–2.9) [6]. Pain on the 0–10 scale: 1.5 exercise vs 2.7 injection vs 3.8 wait-and-see [6]. Then the trial's second half, the one that decides dosing doctrine: at fifty-two weeks the injection's early shine had faded to a pain tie with exercise, while global improvement still favored the program — 51/65 vs 36/63, a 20.4% (4.9–35.9) risk difference, NNT 4.9 [6]. The syringe buys weeks; the program buys the year. And the program in question is a loading program — progressive tendon dosing of the very structures that hurt — delivered alongside education about load management, not rest [6]. For the gym reader this is the umbrella door's centerpiece: the lateral hip that hurts when you train is, in its most common form, a tendon asking for a better dose, not a vacation.

The joint file: the honesty null, the strength dose, and the guideline house

When the pain is the joint itself — groin stiffness in the morning, grinding deep in the socket, the classic degenerative pattern — the hip file is more honest than the knee's, and that honesty is printed in its best journals. The randomized trial of 102 hip-osteoarthritis patients comparing active physical therapy against sham ultrasound and gel found no significant difference at 13 weeks: pain mean difference 6.9 mm favoring sham (95% CI −3.9 to 17.7), WOMAC function 1.4 units favoring sham (−3.8 to 6.5), adverse effects 41% vs 14% (P=.003) [7]. A generic therapy program, in hip OA, did not beat attention placebo — the file's null column, and the reason dose and progression are not optional. Because the dose column reads the opposite way: 160 Danes with hip osteoarthritis, twelve weeks of progressive resistance training versus neuromuscular exercise — both arms improved ~9 points of HOOS pain (+8.6 vs +9.3, difference −0.7 (−5.3 to 4.0)) with equal chair-stand gains (+1.5 vs +1.5) [8]. Heavy, progressive, gym-shaped loading matched the clinical standard for hip OA point for point [8]. Above both sits the guideline house: the EULAR task force — 21 experts, five Delphi rounds — issued 11 evidence-based recommendations across nine topics with exercise in the core management of hip and knee osteoarthritis, agreement 8.0–9.1/10, while flagging in its research agenda "an overall need for more research into non-pharmacological interventions for hip OA" [9]. Read the three together and the doctrine assembles itself: the hip file is thinner than the knee file (the guideline says so [9]), generic programs can wash out against placebo [7], but progressive loading is a legitimate, guideline-backed, trial-equivalent modality [8][9] — which is precisely the thing a barbell library knows how to deliver. The full degenerative chapters live behind the osteoarthritis door.

The impingement file: surgery's honest margin

The structural door inside this wing — femoroacetabular impingement, the cam-or-pincer shaped hip that pinches at depth — is where the surgery question gets asked loudest, and three randomized trials now price it. The UK FASHIoN trial across 23 NHS hospitals randomized 348 patients to hip arthroscopy or to personalised hip therapy: at twelve months, iHOT-33 went 39.2→58.8 with surgery versus 35.6→49.7 with therapy — an adjusted mean difference of 6.8 points (95% CI 1.7–12.0, p=0.0093) favoring surgery, just past the 6.1 MCID — while the therapy arm still gained fourteen points, adverse events touched 72% vs 60% of patients, and seven serious events plus one post-surgical joint infection balanced the ledger [10]. The UK FAIT trial in 222 patients (112 surgery / 110 physiotherapy plus activity modification) found HOS-ADL at eight months of 78.4 versus 69.2 — adjusted mean difference 10.0 points (6.4–13.6), P<0.001, no serious adverse events in either arm — the surgery margin in its cleanest form, on a physiotherapy arm that still moved substantially [11]. Then the 38-month follow-up tempers all of it: no significant difference in minimum joint space width — the structural endpoint the whole operation nominally protects — while HOS-ADL still favored arthroscopy (84.2 vs 74.2, difference 8.9 (7.0–10.8)) and MRI damage scores ran lower in operated hips (SHOMRI 9.22 vs 22.76), printed with follow-up completeness of 45–77% as the honest caveat [12]. The synthesis for the umbrella reader: surgery wins the patient-reported margin in these selected trials and does not (yet) prove structural protection [10][11][12]; physiotherapy-based care improves most patients by double digits without an operation [10][11]; and neither arm licenses the third option — doing nothing, which is the only arm the wait-and-see data penalizes [6]. If you carry a confirmed structural file, the surgeon conversation is real and worth having with these three trials in hand; the training question has the same answer either way.

The Brazilian ledger: the shapes are normal and the gyms are full of them

The home market prices this door from both sides. On the morphology side, the UNIFESP São Paulo study compared 60 Brazilian professional adult male soccer players against 32 male controls: morphological femoroacetabular impingement in 92.5% of the professionals versus 28.1% of controls (p<0.001) — with longer careers correlating with higher alpha angles (p=0.033), retroversion falling as careers lengthened (p=0.009), and earlier competitive starts producing worse morphology (p<0.001) [13]. In the country's biggest sport, an impingement-shaped hip is not the exception; it is near-universal — and careers run for decades on those hips anyway. On the gym side, the USP São Paulo survey of 113 competitive bodybuilders (mean age 30.5) found 8 (7%) with hip pain in the preceding week, only 2 (1.7%) with a positive anterior impingement sign — and none of the symptomatic athletes interrupted training or performance, the authors noting plainly that "symptomatic athletes continued their training program under the presence of hip pain" [14]. Between the 92.5% and the 7% sits this entire guide's thesis: the shapes that frighten scans are endemic in Brazilian athletics [13], the pain that brings readers to this door is comparatively rare in the training population [14], and the population that carries both tends to keep training — the question is whether it does so calibrated or blind. That is what "pode fazer academia com dor no quadril?" is really asking, and why this file exists in Portuguese.

The fences: red flags, referrals, and honest limits

The fences at this door are real, and the first one is hard. The red-flag set stops the program and opens a medical door today: a hip that cannot bear weight after a fall or trauma, or that sits shortened and rotated after injury, is a fracture conversation, not a training decision; a hot, red, feverish hip is a same-day infection file; night pain that wakes you, unexplained weight loss, or a history of cancer puts malignancy on the list; groin pain in someone on chronic corticosteroids (or with sickle cell disease, or a diving-heavy history) raises the femoral-head file — avascular necrosis — which is diagnosed early or missed; a pulsatile groin mass or a lump at the hernia sites belongs to the surgeon who examines it. The second fence is the diagnosis fence: this door is not a diagnostic service, the pain-as-signal dosing below assumes nothing structural is being missed, and the assessment that separates the 23% from the 77% [5] is a clinical examination — duration, severity, internal rotation, imaging read together — not a self-test. The third is the honesty fence: the hip-OA exercise file carries a published null against sham [7] and the guideline's own admission that hip evidence is thin [9]; the surgery trials favor arthroscopy on symptoms without (yet) proving structure [10][11][12]; the LEAP trial's population was lateral-hip tendinopathy, not every groin ache [6]; and 23% of new presenters do end up listed for a replacement within four years [5] — the surgeon is not the enemy, the default was the mistake. None of that reverses the direction of the file. All of it prices the confidence honestly.

The protocol: six rules

  1. Triage before you train. Trauma with inability to bear weight, deformity after a fall, fever with a hot joint, night pain with weight loss, steroid use with groin pain, a groin lump — the program stops and the right clinician starts [5]. Everything below is for the hip that hurts without a red flag.
  2. Read pain as a signal, not a stop sign — and not background noise either. The winning trials trained within tolerance: pain that settles back to baseline within 24 hours and does not climb week over week is acceptable dosing; pain that spikes, lingers past a day, or wakes you at night is a down-shift and, if it persists two to three weeks, an assessment [6][8].
  3. Modify the depth and the dose; keep the membership. The impingement-shaped hip often tolerates a box squat or a wider stance before it tolerates the full-depth narrow version — cut depth, widen stance, swap the barbell for machines where tolerance demands, trade running volume for cycling days — and keep training. The wait-and-see arm is the only arm the data penalizes [6], and "wait until pain-free" was never a column in any of these files.
  4. Load the tendon and the chain that serves the hip. The lateral hip answered to progressive loading plus education, beat the injection at eight weeks and at fifty-two [6]; the arthritic hip answered twelve weeks of heavy progressive resistance with the same ~9-point improvement as the clinical program [8]. Deliver it with progressive overload from whatever load today permits — glutes, abductors, quads, hamstrings — inside a proper warm-up.
  5. Do not buy an operation before the program has had its trial. The physiotherapy arms of the surgery trials improved by double digits [10][11]; the structural endpoint at 38 months did not separate [12]; and the EULAR house keeps exercise in core management [9]. If you carry a confirmed structural file and months of compliant dosing has not bent the trend, the surgeon conversation is legitimate — with these trials in hand, not instead of them.
  6. Persist, track, and re-check at the deadline. The LEAP advantage at a year belonged to the patients still improved at a year [6]; the strength dose took twelve weeks to print its 9 points [8]. If six to twelve weeks of compliant dosing has not bent the trend, escalate to imaging and a specialist — the answer is rarely a procedure by default [10][11][12], not that assessments are optional.

How RightRep fits into this

The hard part of training through an undiagnosed hip is not courage; it is calibration — knowing whether this week's program is tolerable dosing or quiet provocation, whether the squat is quietly changing shape to protect the pinch, and whether the trend is actually bending. That is a measurement problem, and it is what the app does:

  • The rep score trend is the tolerability graph. Pain makes every set feel unreliable; an objective per-session quality score, trending week over week against your symptoms, shows whether the modified program is landing — the year-long LEAP advantage [6] is delivered by sessions you can actually see happening.
  • Form checks catch the protective compensation. A guarding hip changes squat mechanics — depth drifts, weight shifts to the painless side, stance creeps wider — and a camera that grades every set notices the limp before it becomes the way you lift.
  • Depth and symmetry scoring turn "modify the load" into numbers. Rule 3 is a dosing instruction; a measured, adjustable squat depth and a left-right balance score are how it is enforced rep by rep instead of guessed — the difference between a deliberate box squat and a squat that has quietly become one.
  • Tempo control and rest timers structure the graded return — controlled movement through the tolerated range, honest spacing between sets, and a log that makes week-over-week pain trending a table, not a memory.

Run it at rightrep.app — with the depth modified, the chain loading, and the log proving the trend.

The bottom line

Can you train with hip pain? Yes — after the triage step, with the file priced honestly: osteoarthritis touches 595 million people and the hip is its fastest-growing large-joint projection at +78.6% to 2050 [1], yet one in five hips over fifty shows the X-ray while only one in twenty-five hurts with it [2], pain-free hips carry labral tears in 54% and impingement shapes in the majority [3][4], and 7% of new hip-pain presenters are listed for a replacement within a year, 23% within four — three-quarters on no such trajectory at all [5]; the lateral hip answered to education plus exercise with global improvement in 51/66 at eight weeks (NNT 2.0 vs waiting) and the advantage still alive at fifty-two [6]; hip-OA exercise carries one honest null against sham [7] against twelve weeks of heavy progressive resistance matching the clinical program at ~9 HOOS points [8] under a guideline that keeps exercise in core management [9]; arthroscopy for impingement holds a 6.8 iHOT-33 margin just past MCID at 12 months [10], 10.0 HOS-ADL at 8 months [11], and no structural difference at 38 [12]; and in Brazil, 92.5% of professional soccer players carry the morphology [13] while 113 competitive bodybuilders carry the pain at 7% — none of them stopping [14]. The fences are the red flags: trauma without weight-bearing, deformity, fever with a hot joint, night pain with weight loss, steroid-adjacent groin pain, a groin lump — medicine first, program second [5]. This guide pairs with the named doors behind the umbrella — bursitis, the hip flexor strain, osteoarthritis and the post-replacement files — the umbrella siblings (lower back, knee, shoulder), and tracking your workouts (the mechanism that delivers the adherence dose).

This post was written by the RightRep AI Assistant — the same AI that counts and scores your reps at rightrep.app.

Sources

  1. GBD 2021 Osteoarthritis Collaborators. Global, regional, and national burden of osteoarthritis, 1990-2020 and projections to 2050: a systematic analysis for the Global Burden of Disease Study 2021. Lancet Rheumatology, 2023;5(9):e508–e522. pubmed.ncbi.nlm.nih.gov
  2. Kim C, Matthan H, March L, et al. Prevalence of radiographic and symptomatic hip osteoarthritis in an urban United States community: the Framingham osteoarthritis study. Arthritis & Rheumatology, 2014;66(11):3013–3017. pubmed.ncbi.nlm.nih.gov
  3. Heerey JJ, Kemp JL, Mosler AB, et al. What is the prevalence of imaging-defined intra-articular hip pathologies in people with and without pain? A systematic review and meta-analysis. British Journal of Sports Medicine, 2018;52(9):581–593. pubmed.ncbi.nlm.nih.gov
  4. Frank JM, Harris JD, Erickson BJ, et al. Prevalence of femoroacetabular impingement imaging findings in asymptomatic volunteers: a systematic review. Arthroscopy, 2015;31(6):1199–1204. pubmed.ncbi.nlm.nih.gov
  5. Birrell F, Afzal C, Nahit E, et al. Predictors of hip joint replacement in new attenders in primary care with hip pain. British Journal of General Practice, 2003;53(486):26–30. pubmed.ncbi.nlm.nih.gov
  6. Mellor R, Bennell K, Grimaldi A, et al. Education plus exercise versus corticosteroid injection use versus a wait and see approach on global outcome and pain from gluteal tendinopathy: prospective, single blinded, randomised clinical trial. BMJ, 2018;361:k1662. pubmed.ncbi.nlm.nih.gov
  7. Bennell KL, Egerton T, Martin J, et al. Effect of physical therapy on pain and function in patients with hip osteoarthritis: a randomized clinical trial. JAMA, 2014;311(19):1987–1997. pubmed.ncbi.nlm.nih.gov
  8. Kjeldsen T, Skou ST, Dalgas U, et al. Progressive resistance training or neuromuscular exercise for hip osteoarthritis: a multicenter cluster randomized controlled trial. Annals of Internal Medicine, 2024;177(5):573–582. pubmed.ncbi.nlm.nih.gov
  9. Fernandes L, Hagen KB, Bijlsma JW, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Annals of the Rheumatic Diseases, 2013;72(7):1125–1135. pubmed.ncbi.nlm.nih.gov
  10. Griffin DR, Dickinson EJ, Wall PDH, et al. Hip arthroscopy versus best conservative care for the treatment of femoroacetabular impingement syndrome (UK FASHIoN): a multicentre randomised controlled trial. The Lancet, 2018;391(10136):2225–2235. pubmed.ncbi.nlm.nih.gov
  11. Palmer AJR, Ayyar Gupta V, Fernquest S, et al. Arthroscopic hip surgery compared with physiotherapy and activity modification for the treatment of symptomatic femoroacetabular impingement: multicentre randomised controlled trial. BMJ, 2019;364:l185. pubmed.ncbi.nlm.nih.gov
  12. Palmer A, Fernquest S, Rombach I, et al. Medium-term results of arthroscopic hip surgery compared with physiotherapy and activity modification for the treatment of symptomatic femoroacetabular impingement: multicentre randomised controlled trial. British Journal of Sports Medicine, 2025;59(2):109–117. pubmed.ncbi.nlm.nih.gov
  13. Falotico GG, Arliani GG, Yamada AF, et al. Professional soccer is associated with radiographic cam and pincer hip morphology. Knee Surgery, Sports Traumatology, Arthroscopy, 2019;27(10):3142–3148. pubmed.ncbi.nlm.nih.gov
  14. Fagotti L, Ejnisman L, Almeida-Santos MA, et al. Epidemiology of hip pain in Brazilian bodybuilders. Acta Ortopedica Brasileira, 2021;29(3):124–126. pubmed.ncbi.nlm.nih.gov